Oasmia Pharmaceutical AB Buy Hold or Sell Recommendation

OASMYDelisted Stock  USD 0.06  0.00  0.00%   
Assuming the 90 days horizon and your complete indifference towards market risk, our recommendation regarding Oasmia Pharmaceutical AB is 'Not Rated'. A buy or sell recommendation is an automated directive regarding whether to purchase or sell Oasmia Pharmaceutical AB given historical horizon and risk tolerance. When we issue a 'buy' or 'sell' recommendation for Oasmia Pharmaceutical AB, the advice is generated through an automated system that utilizes algorithms and statistical models.
  
Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population.
In addition, we conduct extensive research on individual companies such as Oasmia and provide practical buy, sell, or hold advice based on investors' investing horizon and their risk tolerance towards Oasmia Pharmaceutical AB. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population.

Execute Oasmia Pharmaceutical Buy or Sell Advice

The Oasmia recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on Oasmia Pharmaceutical AB. Macroaxis does not own or have any residual interests in Oasmia Pharmaceutical AB or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Oasmia Pharmaceutical's advice using the current market data and latest reported fundamentals.

Time Horizon

Risk Tolerance

Execute Advice
Sell Oasmia PharmaceuticalBuy Oasmia Pharmaceutical
Not Rated
For the selected time horizon Oasmia Pharmaceutical AB has a Risk Adjusted Performance of 0.0118, Jensen Alpha of (0.21), Total Risk Alpha of (2.43) and Treynor Ratio of 0.0161
We provide trade recommendations to complement the recent expert consensus on Oasmia Pharmaceutical. Our dynamic recommendation engine exercises a multidimensional algorithm to analyze the firm's potential to grow using all technical and fundamental data available at the time. To make sure Oasmia Pharmaceutical is not overpriced, please check all Oasmia Pharmaceutical fundamentals, including its gross profit, short ratio, as well as the relationship between the Short Ratio and annual yield . As Oasmia Pharmaceutical appears to be a penny stock we also advise to check out its price to book numbers.

Oasmia Pharmaceutical Trading Alerts and Improvement Suggestions

Oasmia Pharmaceutical is not yet fully synchronised with the market data
Oasmia Pharmaceutical has some characteristics of a very speculative penny stock
Oasmia Pharmaceutical has a very high chance of going through financial distress in the upcoming years
The company reported the revenue of 26.19 M. Net Loss for the year was (132.72 M) with loss before overhead, payroll, taxes, and interest of (15.25 M).
Oasmia Pharmaceutical generates negative cash flow from operations

Oasmia Pharmaceutical Returns Distribution Density

The distribution of Oasmia Pharmaceutical's historical returns is an attempt to chart the uncertainty of Oasmia Pharmaceutical's future price movements. The chart of the probability distribution of Oasmia Pharmaceutical daily returns describes the distribution of returns around its average expected value. We use Oasmia Pharmaceutical AB price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of Oasmia Pharmaceutical returns is essential to provide solid investment advice for Oasmia Pharmaceutical.
Mean Return
0.07
Value At Risk
-16.67
Potential Upside
0.00
Standard Deviation
23.84
   Return Density   
       Distribution  
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of Oasmia Pharmaceutical historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.

Oasmia Pharmaceutical Market Momentum

Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as Oasmia . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.

About Oasmia Pharmaceutical Buy or Sell Advice

When is the right time to buy or sell Oasmia Pharmaceutical AB? Buying financial instruments such as Oasmia Pink Sheet isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.

Use Investing Ideas to Build Portfolios

In addition to having Oasmia Pharmaceutical in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Russia On Wall Street Thematic Idea Now

Russia On Wall Street
Russia On Wall Street Theme
Cross-sector and cross-instrument bundle of publicly traded Russian entities that are expected to be listed on USA exchanges or over the counter. The Russia On Wall Street theme has 23 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Russia On Wall Street Theme or any other thematic opportunities.
View All  Next Launch
Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population.
You can also try the Stocks Directory module to find actively traded stocks across global markets.

Other Consideration for investing in Oasmia Pink Sheet

If you are still planning to invest in Oasmia Pharmaceutical check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Oasmia Pharmaceutical's history and understand the potential risks before investing.
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Bonds Directory
Find actively traded corporate debentures issued by US companies
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Piotroski F Score
Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Odds Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Technical Analysis
Check basic technical indicators and analysis based on most latest market data